Evidence map›Paper›PMID 9852319›Full record

ArticleThe Journal of physiology1999

Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones.

I Shibuya, K Tanaka, Y Hattori, Y Uezono, N Harayama, J Noguchi, Y Ueta, F Izumi, H Yamashita

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 124 citations in OpenAlex.

  1. Review
  2. Contribution of P2X4 Receptors to CNS Function and Pathophysiology.International journal of molecular sciences · 2020
    Review
  3. Article
  4. Article
  5. Review
  6. Purinergic signaling pathways in endocrine system.Autonomic neuroscience : basic & clinical · 2015
    Review
  7. Article
  8. Purinergic signalling in endocrine organs.Purinergic signalling · 2014
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. P2X receptor channels in endocrine glands.Wiley interdisciplinary reviews. Membrane transport and signaling · 2013
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Characterization of purinergic P2X4 receptor channels expressed in anterior pituitary cells.American journal of physiology. Endocrinology and metabolism · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

I ShibuyaDepartment of Physiology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu 807-8555, Japan. shibuya@med.uoeh-u.ac.jp
K Tanaka
Y Hattori
Y Uezono
N Harayama
J Noguchi
Y Ueta
F Izumi
H Yamashita
University of Occupational and Environmental Health Japan · JPNotre Dame Seishin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. The expression, distribution and function of P2X purinoceptors in the supraoptic nucleus (SON) were investigated by reverse transcription-polymerase chain reaction (RT-PCR), in situ hybridization, and Ca2+-imaging and whole-cell patch-clamp techniques, respectively. 2. RT-PCR analysis of all seven known P2X receptor mRNAs in circular punches of the SON revealed that mRNAs for P2X2, P2X3, P2X4, P2X6 and P2X7 receptors were expressed in the SON, and mRNAs for P2X3, P2X4 and P2X7 were predominant. 3. In situ hybridization histochemistry for P2X3 and P2X4 receptor mRNAs showed that both mRNAs were expressed throughout the SON and in the paraventricular nucleus (PVN). 4. ATP caused an increase in [Ca2+]i in a dose-dependent manner with an ED50 of 1.7 x 10-5 M. The effects of ATP were mimicked by ATPgammaS and 2-methylthio ATP (2MeSATP), but not by AMP, adenosine, UTP or UDP. alphabeta-Methylene ATP (alphabetaMeATP) and ADP caused a small increase in [Ca2+]i in a subset of SON neurones. 5. The P2X7 agonist 2'- & 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) at 10-4 M increased [Ca2+]i, but the potency of BzATP was lower than that of ATP. In contrast, BzATP caused a more prominent [Ca2+]i increase than ATP in non-neuronal cells in the SON. 6. The effects of ATP were abolished by extracellular Ca2+ removal or by the P2 antagonist pyridoxal phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS), and inhibited by extracellular Na+ replacement or another P2 antagonist, suramin, but were unaffected by the P2X7 antagonist oxidized ATP, and the inhibitor of Ca2+-ATPase in intracellular Ca2+ stores cyclopiazonic acid. 7. Two patterns of desensitization were observed in the [Ca2+]i response to repeated applications of ATP: some neurones showed little or moderate desensitization, while others showed strong desensitization. 8. Whole-cell patch-clamp analysis showed that ATP induced cationic currents with marked inward rectification. The ATP-induced currents exhibited two patterns of desensitization similar to those observed in the [Ca2+]i response. 9. The results suggest that multiple P2X receptors, including P2X3, are functionally expressed in SON neurones, and that activation of these receptors induces cationic currents and Ca2+ entry. Such ionic and Ca2+-signalling mechanisms triggered by ATP may play an important role in the regulation of SON neurosecretory cells.

Indexed as

Transcription, GeneticAdenosineAdenosine MonophosphateAdenosine TriphosphateAnimalsCalciumIn Situ HybridizationIn Vitro TechniquesMaleMembrane PotentialsNeuronsParaventricular Hypothalamic NucleusPatch-Clamp TechniquesRatsRats, WistarReceptors, Purinergic P2AdenosineAdenosine MonophosphateAdenosine TriphosphateCalciumReceptors, Purinergic P2RNA, MessengerUracil Nucleotides

Identifiers

PMID9852319
PMCPMC2269088
OpenAlexW1974249330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.